<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30397401</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>06</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">1661-3791</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>4</Volume>                    <Issue>5</Issue>                    <PubDate>                        <Year>2009</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Breast care (Basel, Switzerland)</Title>                <ISOAbbreviation>Breast Care (Basel)</ISOAbbreviation>            </Journal>            <ArticleTitle>An Analysis of the Use of Complementary and Alternative Therapies in Patients with Breast Cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>301-307</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1159/000240988</ELocationID>            <Abstract>                <AbstractText Label="Background" NlmCategory="UNASSIGNED">The aim of the present study was to investigate the use of complementary and alternative medicine (CAM) and the factors that influence their use in patients with breast cancer.</AbstractText>                <AbstractText Label="Patients and Methods" NlmCategory="UNASSIGNED">This descriptive and cross-sectional study was carried out with 135 breast cancer patients on chemotherapy.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">30.4% of patients admitted using one or more CAM methods. The most common method was herbal therapy (97.6%). There were statistically significant differences among CAM users and non-users in terms of time elapsed since initial diagnosis, current stage of the disease, and current type of therapy. As the time since the initial diagnosis increased, so did the percentage of CAM users. Those patients with advanced stage cancer or relapsed disease who were receiving palliative therapy used CAM methods more than those receiving adjuvant therapy. As far as quality of life was concerned, symptoms such as nausea and vomiting, dyspnea, and diarrhea were more common among CAM users.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">It is important and necessary that health professionals working in oncology clinics are made aware of the common use of CAM methods so that they can provide the necessary communication between patients and other health professionals on these treatment modalities.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Tarhan</LastName>                    <ForeName>Oktay</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>Clinic of Medical Oncology, Izmir Ataturk Training and Research Hospital, Izmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Muslu</LastName>                    <ForeName>Ugur</ForeName>                    <Initials>U</Initials>                    <AffiliationInfo>                        <Affiliation>3rd Clinic of Internal Medicine, Izmir Ataturk Training and Research Hospital, Izmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Somali</LastName>                    <ForeName>Isil</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Clinic of Medical Oncology, Izmir Ataturk Training and Research Hospital, Izmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Erten</LastName>                    <ForeName>Cigdem</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Clinic of Medical Oncology, Izmir Ataturk Training and Research Hospital, Izmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Alacacioglu</LastName>                    <ForeName>Ahmet</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Clinic of Medical Oncology, Izmir Ataturk Training and Research Hospital, Izmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Varol</LastName>                    <ForeName>Sengul</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Clinic of Medical Oncology, Izmir Ataturk Training and Research Hospital, Izmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Aslan</LastName>                    <ForeName>Leyla</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>3rd Clinic of Internal Medicine, Izmir Ataturk Training and Research Hospital, Izmir, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2009</Year>                <Month>10</Month>                <Day>01</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Switzerland</Country>            <MedlineTA>Breast Care (Basel)</MedlineTA>            <NlmUniqueID>101254060</NlmUniqueID>            <ISSNLinking>1661-3791</ISSNLinking>        </MedlineJournalInfo>        <OtherAbstract Type="Publisher" Language="por">            <AbstractText Label="Hintergrund" NlmCategory="UNASSIGNED">Ziel dieser Studie war es, die Anwendung komplementär- und alternativmedizinischer (CAM) Methoden sowie Faktoren, die deren Einsatz bei Brustkrebspatienten beeinflussen, zu untersuchen.</AbstractText>            <AbstractText Label="Patienten und Methoden" NlmCategory="UNASSIGNED">Die vorliegende beschreibende Querschnittsstudie wurde mit 135 chemotherapeutisch behandelten Brustkrebspatientinnen durchgeführt.</AbstractText>            <AbstractText Label="Ergebnisse" NlmCategory="UNASSIGNED">30.4% der Patientinnen gaben an, eine oder mehrere CAM-Methoden anzuwenden. Am häufigsten wurden kräutermedizinische Methoden eingesetzt (97.6%). Zwischen Benutzern und Nicht-Benutzern von CAM betanden statistisch signifikante Unterschiede bezüglich der Zeit seit Erstdiagnose, dem aktuellen Krankheitsstadium und der derzeitig angewendeten Therapieform. Mit wachsender Zeitspanne seit Erstdiagnose nahm auch der Anteil an CAM-Benutzern zu. Palliativ behandelte Patientinnen im fortgeschrittenen oder rezidivierten Stadium wendeten CAM häufiger an als adjuvant behandelte Patientinnen. In Bezug auf die Lebensqualität waren Symptome wie Übelkeit und Erbrechen, Dyspnoe und Durchfall unter CAM-Benutzern weiter verbreitet.</AbstractText>            <AbstractText Label="Schlussfolgerung" NlmCategory="UNASSIGNED">Es ist wichtig und notwendig, dass sich in der Onkologie tätige Mediziner der Existenz von CAM-Methoden bewusst werden, so dass sie die nötige Kommunikation zwischen Patienten und Angehörigen anderer Gesundheitsberufe hinsichtlich dieser Behandlungsmodalitäten bereitstellen können.</AbstractText>        </OtherAbstract>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Complementary and alternative therapy</Keyword>            <Keyword MajorTopicYN="N">Quality of life</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2009</Year>                <Month>11</Month>                <Day>1</Day>                <Hour>0</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2009</Year>                <Month>11</Month>                <Day>1</Day>                <Hour>0</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30397401</ArticleId>            <ArticleId IdType="doi">10.1159/000240988</ArticleId>            <ArticleId IdType="pii">brc-0004-0301</ArticleId>            <ArticleId IdType="pmc">PMC6206946</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>